Medical devices early assessment methods: Systematic literature review

International Journal of Technology Assessment in Health Care

Volumn 30, Issue 2, 2014, Pages 137-146

  Markiewicz, Katarzyna ^a   Van Til, Janine A ^a   Ijzerman, Maarten J ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Cost effectiveness; Health technology assessment; Healthcare economics and organizations; Medical devices; Translational research

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS; ECONOMIC ANALYSIS; PRODUCT DEVELOPMENT;

COST EFFECTIVENESS ANALYSIS; HEALTH TECHNOLOGY ASSESSMENTS; HEALTHCARE ECONOMICS; MEDICAL DEVICE DEVELOPMENT; MEDICAL DEVICES; PRODUCT DEVELOPMENT STAGES; SYSTEMATIC LITERATURE REVIEW; TRANSLATIONAL RESEARCH;

BIOMEDICAL EQUIPMENT;

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DATA EXTRACTION; DEVELOPMENTAL STAGE; ECONOMIC EVALUATION; HUMAN; INFORMATION RETRIEVAL; MEDICAL ASSESSMENT; MEDICAL DEVICE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REFERENCE DATABASE; REVIEW; SYSTEMATIC REVIEW; BIOMEDICAL TECHNOLOGY ASSESSMENT; DEVICES; PROCEDURES;

EQUIPMENT AND SUPPLIES; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84902077100     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462314000026     Document Type: Review

References (124)

1. Bartelmes M, Neumann U, Lühmann D, Schönermark MP, Hagen A. Methoden zur frühen entwicklungsbegleitenden Bewertung innovativer medizinischer Technologien. GMS Health Technol Assess. 2009;5:15.
2. Lim ME, O'Reilly D, Tarride JE, et al. Health technology assessment for radiologists: Basic principles and evaluation framework. J Am Coll Radiol. 2009;6:299-306.
3. Vallejo-Torres L, Steuten LMG, Parkinson B, Girling AJ, Buxton MJ. Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach. Int J Technol Assess Health Care. 2008;24:459-464.
4. Goodman CS, Ahn R. Methodological approaches of health technology assessment. Int J Med Inform. 1999;56:97-105.
5. Ferrusi IL, Ames D, Lim ME, Goeree R. Health technology assessment from a Canadian device industry perspective. J Am Coll Radiol. 2009;6:353-359.
6. Hummel JM, van Rossum W, Verkerke GJ, Rakhorst G. Assessing medical technologies in development; a new paradigm of medical technology assessment. Int J Technol Assess Health Care. 2000;16:1214-1219.
7. Ibargoyen-Roteta N, Gutierrez-Ibarluzea I, Asua J, Benguria-Arrate G, Galnares-Cordero L. Differences in the identification process for new and emerging health technologies: Analysis of the EuroScan database. Int J Technol Assess Health Care. 2009;25:249-254.
8. International Network of Agencies for Health Technology Assessment (INAHTA). http://www.inahta.org/HTA/(accessed April 16, 2014).
9. Cosh E, Girling A, Lilford R, McAteer H, Young T. Investing in new medical technologies: A decision framework. J Commer Biotechnol. 2007;13:263-271.
10. IJzerman MJ, Steuten LMG. Early assessment of medical technologies to inform product development and market access: A review of methods and applications. Appl Health Econ Health Policy. 2011;9:331-347.
11. Hilgerink MP, Hummel JM, Manohar S, Vaartjes SR, IJzerman MJ. Assessment of the added value of the Twente Photoacoustic Mammoscope in breast cancer diagnosis. Med Dev Evid Res. 2011;4:107-115.
12. Van der Wetering G, Steuten LMG, von Birgelen C, Adang EMM, IJz-erman MJ. Early Bayesian modeling of a potassium lab-on-a-chip for monitoring of heart failure patients at increased risk of hyperkalaemia. Technol Forecast Soc. 2012;79:1268-1279.
13. Ballini L, Minozzi S, Negro A, Pirini G, Grilli R. A method for addressing research gaps in HTA, developed whilst evaluating robotic-assisted surgery: Assisted proposal. Health Res Policy Syst. 2010;8:27-35.
14. Girling A, Young T, Brown C, Lilford R. Early stage valuation of medical devices: The role of developmental uncertainty. Value Health. 2010;13:585-591.
15. Ahn MJ, Zwikael O, Bednarek R. Technological invention to product innovation: A project management approach. Int J Proj Manage. 2010;28:559-568.
16. Hartz S, John J. Public health policy decisions on medical innovations: What role can early economic evaluation play? Health Policy. 2009;89:184-192.
17. Sculpher M, Drummond M, Buxton M. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy. 1997;2:26-30.
18. Fenwick E, Palmer S, Claxton K, et al. An iterative Bayesian approach to health technology assessment: Application to a policy of preoperative optimization for patients undergoing major elective surgery. Med Decis Making. 2006;26:480-496.
19. Pietzsch JB, Paté-Cornell ME. Early technology assessment of new medical devices. Int J Technol Assess Health Care. 2008;24:36-44.
20. Bragdon CR, Malchau H, Yuan X, et al. Experimental assessment of precision and accuracy of radiostereometric analysis for the determination of polyethylene wear in a total hip replacement model. J Orthop Res. 2002;20:688-695.
21. Robertson DG, Watkins PB, Reily MD. Metabolomics in toxicology: Preclinical and clinical applications. Toxicol Sci. 2011;120:S146-S170.
22. Santler G. The Graz hemisphere splint: A new precise, non-invasive method of replacing the dental arch of 3D-models by plaster models. J Craniomaxillofac Surg. 1998;26:169-173.
23. Yao Z, Huang K, Guo J, et al. Screening and determinations of tissue polypeptide antigen by label-free optical immunosensing method. J Nanosci Nanotechnol. 2012;12:112-118.
24. Chang HK, Ishikawa FN, Zhang R, et al. Rapid, label-free, electrical whole blood bioassay based on nanobiosensor systems. ACS Nano. 2011;5:9883-9891.
25. Schumland C. Value-added medical-device risk management. IEEE Trans device mater reliabil. 2005;5:488-493.
26. Alexander G, Staggers N. A systematic review of the designs of clinical technology: Findings and recommendations for future research. Adv Nurs Sci. 2009;32:252-279.
27. Holtby H, Skowno JJ, Kor DJ, Flick RP, Uezono S. New technologies in pediatric anesthesia. Paediatr Anaesth. 2012;22:952-961.
28. Cavalcanti A, Shirinzadeh B, Kretly LC. Medical nanorobotics for diabetes control. Nanomedicine. 2008;4:127-138.
29. Chávez-Santiago R, Balasingham I, Bergsland J. Ultrawideband technology in medicine: A survey. J Electric Comput Eng. 2012.
30. Taketani F, Hara Y. Characteristics of spherical aberrations in 3 aspheric intraocular lens models measured in a model eye. J Cataract Refract Surg. 2011;37:931-936.
31. Van Til J, Renzenbrink GJ, Groothuis K, IJzerman MJ. A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain. Disabil Rehabil. 2006;28:645-651.
32. Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care. 2008; 21:568-575.
33. Brodtkorb TH. Cost-effectiveness analysis of health technologies when evidence is scarce. 2010: Linköping, Sweden: Center for Medical Technology Assessment, Department of Medical and Health Sciences Linköping University.
34. McAteer H, Cosh E, Freeman G, et al. Cost-effectiveness analysis at the development phase of a potential health technology: Examples based on tissue engineering of bladder and urethra. J Tissue Eng Regen Med. 2007;1:343-349.
35. Dong H, Buxton M. Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement. Int J Technol Assess Health Care. 2006;22:191-202.
36. Pertile P. An extension of the real option approach to the evaluation of health care technologies: The case of positron emission tomography. Int J Health Care Financ Econ. 2009;9:317-332.
37. Sculpher MJ, Claxton K, Drummond M. Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15:677-688.
38. Stein K, Fry A, Round A, Milne R, Brazier J. What value health? A review of health state values used in early technology assessments for NICE. Appl Health Econ Health Policy. 2005;4:219-228.
39. Hartz S, John J. Contribution of economic evaluation to decision making in early phases of product development: A methodological and empirical review. Int J Technol Assess Health Care. 2008;24:465-472.
40. Persson J, Brodtkorb TH, Roback K. Collaboration between academia, manufacturers and healthcare services for development and adoption of medical devices with regard to costs and effects. IFMBE Proc. 2009;25:138-140.
41. Tarricone R, Drummond M. Challenges in the clinical and economic evaluation of medical devices: The case of transcatheter aortic valve implantation. J Med Marketing. 2011;11:221-229.
42. Malone DC, Saverno KR. Evaluation of a wireless handheld medication management device in the prevention of drug-drug interactions in a medicaid population. J Manag Care Pharm. 2012;18:33-45.
43. Bott OJ, Hoffmann I, Bergmann J, et al. HIS modelling and simulation based cost-benefit analysis of a telemedical system for closed-loop diabetes therapy. Int J Med Inform. 2007;76:S447-S455.
44. Yen PY, Bakken S. Review of health information technology usability study methodologies. J Am Med Inform Assoc. 2012;19:413-422.
45. Gallego G, Bridges JFP, Flynn T, Blauvelt BM, Niessen LW. Using best-worst scaling in horizon scanning for hepatocellular carcinoma technologies. Int J Technol Assess Health Care. 2012;28:339-346.
46. Mazzu M, Scalvini S, Giordano A, et al. Wireless-accessible sensor populations for monitoring biological variables. J Telemed Telecare. 2008;14:135-137.
47. Money AG, Barnett J, Kuljis J, et al. The role of the user within the medical device design and development process: Medical device manufacturers' perspectives. BMC Med Inform Decis Mak. 2011;11:15-26.
48. Shah SGS, Robinson I. User involvement in healthcare technology development and assessment: Structured literature review. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2006;19:500-515.
49. De Rouck S, Jacobs A, Leys M. A methodology for shifting the focus of e-health support design onto user needs: A case in the homecare field. Int J Med Inform. 2008;77:589-601.
50. Davey SM, Brennan M, Meenan BJ, McAdam R. Innovation in the medical device sector: An open business model approach for high-tech small firms. Technol Anal StrategManage J. 2011;23:807-824.
51. Sanders PMH, IJzerman MJ, Roach MJ, Gustafson KJ. Patient preferences for next generation neural prostheses to restore bladder function. Spinal Cord. 2010;49:113-119.
52. LeRouge C, Ma J, Sneha S, Tolle K. User profiles and personas in the design and development of consumer health technologies. Int J Med Inform. 2013;82:251-268.
53. Cytryn KN, Patel VL. Reasoning about diabetes and its relationship to the use of telecommunication technology by patients and physicians. Int J Med Inform. 1998;51:137-151.
54. Coughlin JF, Pope JE, Leedle BR. Older adult perceptions of smart home technologies: Implications for research, policy & market innovations in healthcare. ConfProc IEEE Eng Med Biol Soc. 2007;1810-1815.
55. Shah SG, Robinson I, AlShawi S. Developing medical device technologies from users' perspectives: A theoretical framework for involving users in the development process. Int J Technol Assess Health Care. 2009;25:514-521.
56. Alnanih R, Radhakrishnan T, Ormandjieva O. Characterising context for mobile user interfaces in health care applications. Procedia Comput Sci. 2012;10:1086-1093.
57. Sintonen S, Immonen M. Telecare services for aging people: Assessment of critical factors influencing the adoption intention. Comp Hum Behav. 2013;29:1307-1317.
58. Bridgelal Ram M, Grocott PR, Weir H. Issues and challenges of involving users in medical device development. Health Expect. 2008;11:63-71.
59. Hardisty AR, Peirce SC, Preece A, et al. Bridging two translation gaps: A new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform. 2011;80:734-744.
60. Shah SGS, Robinson I. Benefits of and barriers to involving users in medical device technology development and evaluation. Int J Technol Assess Health Care. 2007;23:131-137.
61. Robinson DKR. Co-evolutionary scenarios: An application to prospecting futures of the responsible development of nanotechnology. Technol Forecast Soc. 2009;76:1222-1239.
62. Retel VP, Hummel JM, van Harten WH. Review on early technology assessments of nanotechnologies in oncology. Mol Oncol. 2009;3:394-401.
63. Hummel JM, Boomkamp ISM, Steuten LMG, Verkerke BGJ, IJzerman MJ. Predicting the health economic performance of new non-fusion surgery in adolescent idiopathic scoliosis. J Orthopaed Res. 2012;30:1453-1458.
64. Reis J, McGinty B, Jones S. An e-learning caregiving program for prostate cancer patients and family members. J Med Syst. 2003;27:1-12.
65. Retel VP, Joore MA, Linn SC, Rutgers EJ, Van Harten WH. Scenario drafting to anticipate future developments in technology assessment. BMC Res Notes. 2012;5:442-453.
66. Robinson DKR, Huang L, Guo Y, Porter AL. Forecasting Innovation Pathways (FIP) for new and emerging science and technologies. Technol Forecast Soc. 2013;80:267-285.
67. Hummel JM, van Rossum W, Verkerke GJ, Rakhorst G. Medical technology assessment: The use of the analytic hierarchy process as a tool for multidisciplinary evaluation of medical devices. Int J Artif Organs. 2000;23:782-787.
68. Martin H, Daim TU. Technology roadmap development process (TRDP) for the service sector: A conceptual framework. Technol Soc. 2012;34:94-105
69. Schaeffer NE. The role of human factors in the design and development of an insulin pump. J Diabetes Sci Technol. 2012;6:260-264.
70. Robinson DKR, Propp T. Multi-path mapping for alignment strategies in emerging science and technologies. Technol Forecast Soc. 2008;75:517-538.
71. Kazanjian A, Green CJ. Beyond effectiveness: The evaluation of information systems using a comprehensive health technology assessment framework. Comput Biol Med. 2002;32:165-177.
72. Rogowski WH, Hartz SC, John JH. Clearing up the hazy road from bench to bedside: A framework for integrating the fourth hurdle into translational medicine. BMC Health Serv Res. 2008;8:194-205.
73. Stevens A, Milne R, Lilford R, Gabbay J. Keeping pace with new technologies: Systems needed to identify and evaluate them. Br Med J. 1999;319:1291-1294.
74. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Bayesian methods in health technology assessment: A review. Health Technol Assess. 2000;4:1-130.
75. Stone VI, Lane JP. Modeling technology innovation: How science, engineering, and industry methods can combine to generate beneficial socioeconomic impacts. Implement Sci. 2012;7:44.
76. Ladabaum U, Brill JV, Sonnenberg A. How to value technological innovation: A proposal for determining relative clinical value. Gastroenterology. 2013;144:5-8.
77. Tal O, Hakak N. Early awareness and alert systems for medical technologies in Israel. Int J Technol Assess Health Care. 2012;28:333-338.
78. Douw K, Vondeling H, Oortwijn W. Priority setting for horizon scanning of new health technologies in Denmark: Views of health care stakeholders and health economists. Health Policy. 2006;76:334-345.
79. Oortwijn WJ, Vondeling H, van Barneveld T, van Vugt C, Bouter LM. Priority setting for health technology assessment in The Netherlands: Principles and practice. Health Policy. 2002;62:227-242.
80. Brown IT, Smale A, Verma A, Momandwall S. Medical technology horizon scanning. Australas Phys Eng Sci Med. 2005;28:200-203.
81. Wild C, Langer T. Emerging health technologies: Informing and supporting health policy early. Health Policy. 2008;87:160-171.
82. Douw K, Vondeling H, Sørensen J, Jørgensen T, Sigmund H. "The future should not take us by surprise": Preparation of an early warning system in Denmark. Int J Technol Assess Health Care. 2004;20:342-350.
83. Berry DA. Introduction to Bayesian methods III: Use and interpretation of Bayesian tools in design and analysis. Clin Trials. 2005;2:295-300.
84. O'Malley SP, Jordan E. Horizon scanning of new and emerging medical technology in Australia: Its relevance to medical services advisory committee health technology assessments and public funding. Int J Technol Assess Health Care. 2009;25:374-382.
85. Postmus D, de Graaf G, Hillege HL, Steyerberg EW, Buskens E. A method for the early health technology assessment of novel biomarker measurement in primary prevention programs. Stat Med. 2012;31:2733-2744.
86. Laking GR, Price PM, Sculpher MJ. Assessment of the technology for functional imaging in cancer. Eur J Cancer. 2002;38:2194-2199.
87. Okamoto E, Hashimoto T, Inoue T, Mitamura Y. Blood compatible design of a pulsatile blood pump using computational fluid dynamics and computer-aided design and manufacturing technology. Artif Organs. 2003;27:61-67.
88. Clopton BM, Spelman FA. Technology and the future of cochlear implants. Ann Otol Rhinol Laryngol Suppl. 2003;191:26-32.
89. Fukamachi K. New technologies for mechanical circulatory support: Current status and future prospects of CorAide and MagScrew technologies. J Artif Organs. 2004;7:45-57.
90. Chang WC, Sretavan DW. Microtechnology inmedicine: The emergence of surgical microdevices. Clin Neurosurg. 2007;54:137-147.
91. Cannesson M, Rinehart J. Innovative technologies applied to anesthesia: How will they impact the way clinicians practice? J Cardiothorac Vasc Anesth. 2012;26:711-720.
92. Carrara S. Nano-bio-technology and sensing chips: New systems for detection in personalized therapies and cell biology. Sensors. 2010;10:526-543.
93. Chatterjee C, Srinivasan V. Ethical issues in health care sector in India. IIMB ManagRev. 2013; 25:49-62.
94. Edelmuth RCL, Nitsche MA, Battistella L, Fregni F. Why do some promising brain-stimulation devices fail the next steps of clinical development? Exp Rev Med Dev. 2010;7:67-97.
95. Edwards B. The future of hearing aid technology. Trends Amplif 2007;11:31-45.
96. Elhawary H, Tse ZT, Hamed A, et al. The case for MR-compatible robotics: A review of the state of the art. Int J Med Robot. 2008;4:105-113.
97. Gervais L, De Rooij N, Delamarche E. Microfluidic chips for point-of-care immunodiagnostics. AdvMater. 2011;23:H151-H176.
98. Granger BB, Bosworth HB. Medication adherence: Emerging use of technology. CurrOpin Cardiol. 2011;26:279-287.
99. Habash RWY, Bansal R, Krewski D, Alhafid HT. Thermal therapy, Part III: Ablation techniques. Crit Rev BiomedEng. 2007;35:37-121.
100. Holloway CMB, Easson A, Escallon J. Technology as a force for improved diagnosis and treatment of breast disease. Can J Surg. 2010;53:268-277.
101. Hovorka R. Closed-loop insulin delivery: From bench to clinical practice. Nat Rev Endocrinol. 2011;7:385-395.
102. Lavee J, Paz Y. Mechanical alternatives to the human heart: Future devices. Isr Med Assoc J. 2002;4:290-293.
103. McMullan JT, Knight WA, Clark JF, Beyette FR, Pancioli A. Time-critical neurological emergencies: The unfulfilled role for point-of-care testing. Int JEmerg Med. 2010;3:127-131.
104. Micera S, Bonato P, Tamura T. Gerontechnology. IEEE Eng Med Biol Mag. 2008;27:10-14.
105. Najarian S, Fallahnezhad M, Afshari E. Advances in medical robotic systems with specific applications in surgery-a review. J Med Engine Technol. 2011;35:19-33.
106. Patel DN, Bailey SR. Nanotechnology in cardiovascular medicine. Catheter Cardiovasc Interv. 2007;69:643-654.
107. Percevic R, Lambert MJ, Kordy H. Computer-supported monitoring of patient treatment response. J Clin Psychol. 2004;60:285-299.
108. Peterhans M, Oliveira T, Banz V, Candinas D, Weber S. Computer-assisted liver surgery: Clinical applications and technological trends. Crit Rev Biomed Eng. 2012;40:199-220.
109. Pfister BJ, Gordon T, Loverde JR, et al. Biomedical engineering strategies for peripheral nerve repair: Surgical applications, state of the art, and future challenges. Crit Rev Biomed Eng. 2011;39:81-124.
110. Postma TJ, Alers JC, Terpstra S, Zuurbier A. The future of imaging techniques for cancer patients in the Netherlands: A Delphi study. Eur J Health Econ. 2006;7:117-122.
111. Prager RW, Ljaz UZ, Gee AH, Treece GM. Three-dimensional ultrasound imaging. Proc Inst Mech EngH. 2010;224:193-223.
112. Rosengart TK, Feldman TC, Borger MA, et al. Percutaneous and minimally invasive valve procedures: A scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Trans-lational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2008;117:1750-1767.
113. Russell-Minda E, Jutai J, Speechley M, et al. Health technologies for monitoring and managing diabetes: A systematic review. J Diabetes Sci Technol. 2009;3:1460-1471.
114. Sahandi R, Noroozi S, Roushan G, Heaslip V, Liu Y. Wireless technology in the evolution of patient monitoring on general hospital wards. J Med Eng Technol. 2010;34:51-63.
115. Scherer MJ, Hart T, Kirsch N, Schulthesis M. Assistive technologies for cognitive disabilities. Crit Rev Phys Rehabil Med. 2005;17:195-215.
116. Schleyer T, Mattsson U, Ni Riordain R, et al. Advancing oral medicine through informatics and information technology: A proposed framework and strategy. Oral Dis. 2011;17:85-94.
117. Baumgart DC. Personal digital assistants in health care: Experienced clinicians in the palm of your hand? Lancet. 2005;366:1210-1222.
118. Azari A, Nikzad S. Computer-assisted implantology: Historical background and potential outcomes-A review. Int J Med Robot. 2008;4:95-104.
119. Paradise J, Diliberto GM, Tisdale AW, Kokkoli E. Exploring emerging nanobiotechnology drugs and medical devices. Food Drug Law J. 2008;63:407-420.
120. Backhouse ME, Wonder M, Hornby E. Early dialogue between the developers of new technologies and pricing and reimbursement agencies: A pilot study. Value Health. 2011;14:608-615.
121. De Rouck S, Jacobs A, Leys M. A methodology for shifting the focus of e-health support design onto user needs: A case in the homecare field. Int J Med Inform. 2008;77:589-601.
122. Goeree R, Levin L, Chandra K, et al. Health technology assessment and primary data collection for reducing uncertainty in decision making. J Am Coll Radiol. 2009;6:332-342.
123. Abalos E, Carroli G, Mackey ME. The tools and techniques of evidence-based medicine. Best Pract Res Clin Obstet Gynaecol. 2005;19:15-26.
124. Bojke L, Claxton K, Sculpher M, Palmer S. Characterizing structural uncertainty in decision analytic models: A review and application of methods. Value Health. 2009;12:739-749.